Related Experiment Videos
Pathophysiology of hypertension: effects of calcium antagonists on heart and kidney
1Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121.
Insights
Hypertension increases total peripheral resistance, impacting organs like the brain, heart, and kidney. Calcium antagonists effectively lower blood pressure by reducing vascular resistance without adverse effects.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Pharmacology
Background:
- Hypertension is a complex condition characterized by increased total peripheral resistance.
- This leads to vasoconstriction in arterioles and venules, affecting vital organs such as the brain, heart, and kidneys.
- Left ventricular afterload increases, potentially causing concentric hypertrophy and complications like cardiac failure.
Purpose of the Study:
- To evaluate the efficacy of calcium antagonists in managing hypertension.
- To assess the impact of calcium antagonists on vascular resistance, cardiac function, and renal hemodynamics.
- To determine if calcium antagonists can reverse the pathophysiological complications of hypertension.
Main Methods:
- The study reviews the hemodynamic effects of hypertension and the mechanisms of action of calcium antagonists.
- It analyzes how calcium antagonists influence arterial pressure, vascular resistance, and cardiac parameters.
- The impact on renal blood flow, glomerular hydrostatic pressure, and filtration fraction is examined.
Main Results:
- Calcium antagonists reduce arterial pressure by decreasing vascular resistance.
- These agents do not cause intravascular volume expansion or excessive cardiac stimulation.
- Left ventricular afterload and mass decrease, while renal blood flow improves and glomerular hydrostatic pressure is reduced.
Conclusions:
- Calcium antagonists effectively manage hypertension by lowering vascular resistance and improving cardiac and renal function.
- They offer a therapeutic approach that reverses key pathophysiological changes associated with hypertension.
- These agents represent an ideal treatment option for hypertension, mitigating its target organ damage.
Abstract:
Hypertension is a multifactorial disease that is manifested hemodynamically by an increased total peripheral resistance that is more or less uniformly distributed throughout the organ circulations, especially in its target organs, the brain, heart, and kidney. The vasoconstriction involves venules as well as arterioles. The increased afterload that is imposed upon the left ventricle results in the development of concentric hypertrophy. This may be complicated by a preload component early in hypertension or in patients who are volume-dependent (e.g., obesity, blacks). Eventually, if not treated, dysrhythmias, sudden death, or cardiac failure may supervene. The kidney becomes affected by progressive failure in function related to hemodynamic impairment secondary to afferent, as well as efferent, arteriolar constriction, which increases glomerular hydrostatic pressure. If at all possible, antihypertensive therapy should not be associated with intravascular volume expansion or reflex cardiac stimulation. Calcium antagonists reduce arterial pressure through a fall in vascular resistance without expanding volume or inordinately stimulating the heart. Left ventricular afterload is diminished with associated decrease of left ventricular mass. Moreover, renal blood flow increases while filtration fraction and glomerular hydrostatic pressure diminishes. Thus, these agents approach the ideal in reversing the pathophysiological complications of the disease.